Covid-19 is an opportunity for law firms to examine ways of being more inclusive, especially for those employees who may be dealing with significantly more challenges, say Linklaters’ David Martin, Daniel Danso, and Neha Rao
In the current global Covid-19 climate, diversity and inclusion (D&I) is supremely important to business and those who have a strong foundation in D&I will be reaping the rewards when it comes to the wellbeing of their people. D&I speaks to the heart of taking care of our people. The language of this crisis – …
Continue reading “Diversity and inclusion shouldn’t take a back seat during the pandemic”
William Farrington considers the high-stakes changes and ongoing debates consuming India’s labour market
As the torchbearer of the BRICS economies since its successful globalisation project throughout the ’90s, India’s employment market has been the nexus of an enduring ideological struggle as the nation seeks to reconcile its socialist-era labour legislation with liberalised market policy. The frontline of this struggle is seen in the extensive proposals for legislative reform …
Continue reading “Out with the old, in with the New Delhi labour reforms?”
Nelson Mullins’ Bart Daniel and Elle Klein warn coronavirus labs to beware potential fraud prosecutions under new federal laws
Although the federal government may have relaxed healthcare regulations amid the pandemic in an effort to quickly respond to the growing number of Covid-19 cases, enforcement agencies have not relaxed at all. In fact, they have done just the opposite. With the federal government spending millions of dollars in support of Covid-19 testing and countless …
Continue reading “Covid-19 may have awoken a sleeping bear”
As vice president in charge of portfolio planning and IP litigation at Sun Pharmaceuticals, India’s largest pharma company and the largest Indian pharma company operating in the US, Bharati Nadkarni has been behind some of the biggest pharma cases in recent times. fivehundred catches up with her about developments facing lawyers in the pharma sector
Bharati, please can you explain the challenges you face in bringing litigation in the pharma space? The approach to litigation in the pharmaceuticals sector is a little different from the approach taken in other industries. There are two main reasons for this. First, patents are territorial. A patent approved in the US may not get …
Continue reading “Pain and gain in pharma litigation”
The co-heads of CEE TMT at CMS Cameron McKenna Nabarro Olswang talk about the key issues facing their clients, the firm’s ambitions for the region, and how to balance a successful team
What have been your greatest personal or professional achievements to date and why? Olga: I believe my biggest professional achievement was, in fact, my decision to become a lawyer many years ago. After 20 years in practice, the profession remains my passion and for me, it is not only about prestige but also about the …
Continue reading “Olga Belyakova and Eva Talmacsi: Be brave and stay curious”
Baker McKenzie’s managing partner in Barcelona on seeking balance between fee-earning and management, the external and internal perception of the firm, and the importance of having the right D&I initiatives in place
How would you define the firm’s culture? How is it introduced to new hires? For us, the firm’s culture is a culture that has clear components: the vision presented to Baker McKenzie employees has a strong global perspective, which has the international vocation innate in Baker McKenzie’s DNA, combined with a strong component of local …
Continue reading “Javier Menor: Some of our own lawyers don’t realise the strength of our brand”
Scott Wilson joined DLA Piper’s litigation practice as a partner in the New York office in December 2019. In the following interview, Helen Donegan, US editor (content), speaks with Scott about this move and his reasons for joining DLA Piper, and he shares some insights into his practice
Can you tell me about your background and experience prior to joining DLA Piper? I was a partner at a prominent US litigation firm, Boies Schiller, for six years before I joined DLA Piper. Prior to that, I served as senior advisor and special counsel to the New York Attorney General, which was a formative …
Continue reading “Move watch: Spotlight on Scott Wilson, DLA Piper”
With experience in both in-house and private practice, Arnold & Porter’s Charles Yi talks to Helen Donegan, US editor for content, on diversity in the US government and the legal profession
Charles Yi joined Arnold & Porter’s Financial Services and Legislative and Public Policy practices in 2019. Prior to this move, Charles served as GC of the Federal Deposit Insurance Corporation (FDIC) between 2015 and 2019. Charles was not only the first person of colour to have served as GC of the FDIC, but also the …
Continue reading “Charles Yi: Too much is never enough”
Fountain Court’s Jacob Turner considers the ethical and regulatory issues surrounding the rise of artificial intelligence
The legal press often features articles on AI replacing lawyers. Until recently, there has been much less focus on the question of how lawyers can help society to live alongside AI. AI is unique because unlike any other previous technology, it can act autonomously. This means it can make decisions which were not pre-programmed by …
Continue reading “Are there any decisions which AI should never take?”
In February, Cleary Gottlieb’s managing partner spoke with Helen Donegan, US editor (content), about his role as ‘Listener-in-Chief’, law firms as a talent business, and plans for Cleary Gottlieb’s upcoming 75th anniversary in 2021
You recently began your second term as Cleary Gottlieb’s managing partner. What surprised you the most during your first three years leading the firm? I now have an appreciation for what music fans refer to as Bob Dylan’s ‘Never Ending Tour’ – lawyers are often on the road, but the life of a managing partner …
Continue reading “Michael Gerstenzang: Insights from Cleary’s ‘Listener-in-Chief’”
